1800 202 8726
Lymphoma treatment

R-CHOP: — What Each Drug in the Regimen Does

R-CHOP is the most widely used combination regimen for aggressive B-cell lymphoma. It pairs a targeted antibody — rituximab — with four chemotherapy drugs, each attacking cancer cells through a different mechanism. Understanding what each component does can help you make sense of your treatment plan and what to expect.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026

  • Five drugs, four mechanisms — Each component works differently, reducing the chance that lymphoma cells can become resistant to any single drug.
  • Rituximab is the targeted part — It marks B-cells for destruction by your immune system. The chemotherapy drugs work more broadly, affecting dividing cells.
  • Given as day care — Each cycle is given at the clinic. You go home the same day in most centres.
  • Other rituximab combinations exist — R-CVP and R-Bendamustine are used for different lymphoma types. Your oncologist chooses based on your exact diagnosis.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

R-CHOP pairs rituximab — a targeted antibody — with four chemotherapy drugs: cyclophosphamide, doxorubicin, vincristine, and prednisolone. Each component attacks B-cell lymphoma in a different way, reducing the chance that cancer cells can become resistant to any single drug. NCCN and ESMO recommend this combination as the standard first-line treatment for diffuse large B-cell lymphoma.

What does each letter of R-CHOP stand for?

R — Rituximab (MabThera)
A monoclonal antibody that targets a protein called CD20 on the surface of B-cells. It attaches to lymphoma cells and flags them for destruction by your immune system. Most healthy non-B cells do not carry CD20, so rituximab is more selective than the chemotherapy drugs in the regimen.
C — Cyclophosphamide
An alkylating agent that damages the DNA inside cancer cells, stopping them from copying themselves. It is active across the full cell cycle, which is part of why combination regimens include it alongside drugs that target specific points in cell division.
H — Hydroxydaunorubicin (Doxorubicin)
An anthracycline that disrupts how cancer cells copy and organise their DNA, triggering cell death. It is given through a drip. Because it can affect heart function at high cumulative doses, your team will check your heart before starting and monitor it during treatment.
O — Oncovin (Vincristine)
A plant-derived drug that prevents cancer cells from completing division by blocking the cellular machinery needed to pull chromosomes apart. It is given in small doses. The most common side effect is numbness or tingling in the fingers and toes, which often improves after treatment ends.
P — Prednisolone
A corticosteroid with direct anti-lymphoma activity, not only a drug to manage side effects. It also reduces the inflammation that can occur when large numbers of cancer cells die rapidly. Unlike the other components, it is taken as tablets — usually for several days around each infusion — rather than given through a drip.

Why use five drugs together instead of one?

Each drug in R-CHOP attacks a different step in how a cancer cell survives and divides. Using several together means that even if a lymphoma cell develops resistance to one mechanism, the others are still active against it.

Rituximab adds something the chemotherapy drugs cannot provide. It recruits your own immune system to destroy marked lymphoma cells. The three chemotherapy drugs — cyclophosphamide, doxorubicin, and vincristine — each target a different point in the cell division process.

Prednisolone's role is also more than supportive. It has direct cell-killing activity in B-cell lymphoma and reduces the inflammatory response that can follow rapid tumour breakdown.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What does a course of R-CHOP treatment look like?

R-CHOP is given in cycles, each separated by a rest period that gives your body time to recover. The number of cycles your oncologist recommends depends on your lymphoma type, stage, and response to treatment. Each cycle is given at the clinic and you go home the same day.

Rituximab is infused first and given slowly on the first cycle, because initial doses carry a higher chance of a reaction. Later cycles can often be given faster once your team is confident you tolerate it. The chemotherapy drugs follow. You take prednisolone tablets at home for several days around each infusion.

Your blood count is checked closely between cycles. A low white cell count is the most common reason for a cycle to be delayed. If you develop any fever or feel generally unwell between appointments, call your team the same day — do not wait for your next scheduled visit.

Are there other rituximab combinations besides R-CHOP?

Yes. Rituximab is used with different chemotherapy backbones depending on the lymphoma type and grade. R-CVP — rituximab with cyclophosphamide, vincristine, and prednisolone, without doxorubicin — is used for some lower-grade follicular lymphomas, particularly where avoiding cardiac risk is a priority.

R-Bendamustine pairs rituximab with bendamustine and is used for certain follicular and mantle cell lymphomas. Other combinations exist for specific lymphoma subtypes.

The choice is made by your oncologist based on your exact diagnosis, your age, your heart function, and your overall health. If you want to understand why a particular regimen was chosen for you, that is a reasonable question to ask at your next appointment.

Explore 75 more Blood Cancer Targeted Medicines topics

Drug Deep Dive: Ibrutinib (Imbruvica)

All Blood Cancer Targeted Medicines →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is R-CHOP the same as CHOP — what does rituximab actually add?

CHOP on its own was the standard regimen for aggressive B-cell lymphoma for many years. When rituximab was added to form R-CHOP, outcomes improved substantially for patients whose lymphoma cells carry the CD20 protein — which the majority do. Rituximab adds a targeted mechanism that the chemotherapy drugs cannot provide: it flags cancer cells specifically for destruction by your immune system. NCCN and ESMO now recommend R-CHOP, not CHOP alone, as the standard first-line treatment for eligible patients with diffuse large B-cell lymphoma.

Can R-CHOP damage my heart?

Doxorubicin — the H in CHOP — can affect heart function, particularly when the total dose received across all cycles is high. Before starting R-CHOP, your team will check your baseline heart function, usually with an echocardiogram, and monitor it during treatment. Most people complete a standard course without lasting cardiac effects. If you have existing heart disease, your oncologist will weigh the balance carefully and may recommend a different regimen, such as R-CVP, which does not contain doxorubicin.

What should I do if I develop a fever between cycles?

Call your oncology team the same day and do not wait for your next appointment. A fever when your white cell count is low — called febrile neutropenia — needs same-day assessment, not home management. Your team will tell you before your first cycle what number to call and when to go directly to an emergency department. Avoid taking fever-reducing medicines before speaking to your team, as these can mask a symptom your team needs to be aware of.

Will my hair fall out during R-CHOP?

Hair loss is expected with R-CHOP, primarily because of doxorubicin, and affects most people on this regimen. It usually begins in the weeks after the first cycle. Hair typically starts to grow back after treatment ends. Some people choose to cut their hair short before treatment begins, or to ask about scalp cooling — ask your team whether that option is available and suitable for your situation.

Are there foods or drinks I should avoid during R-CHOP?

Your team will give you specific guidance for your situation. General advice during chemotherapy includes avoiding grapefruit and grapefruit juice, which can interfere with how some drugs are processed in the body. When your white cell count is low, your team may advise extra care with raw or undercooked food to reduce infection risk. Do not take herbal remedies, supplements, or traditional preparations without telling your treating team first — some interact with chemotherapy drugs in ways that affect how they work or increase side effects.

Can I work or travel normally during R-CHOP?

Many people continue working and managing most normal activities during R-CHOP, particularly in the weeks between cycles when energy levels are closer to usual. The days immediately after an infusion are often the most difficult — fatigue, nausea, and reduced immunity are most pronounced then. Travel, particularly international travel, should be discussed with your team in advance, because access to emergency care if you develop a fever matters. Your team can advise on timing around your cycle schedule.

Call now Book free consultation